BMRN Financial Facts

Interest income: 1.34M
Equity in the loss of BioMarin/Genzyme LLC: -186K
See Full Income Statement

Other assets: 60.79M
Other long-term liabilities: 45.85M
See Full Balance Sheet

BioMarin Pharmaceutical Inc. (BMRN) Earnings

  |   Expand Research on BMRN
Next EPS Date 5/23/16 *Est. EPS Growth Rate +100.0% *Last Qtr.
Average EPS % Beat Rate +14.8% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS +1.3% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/25/16 Q415 N/A$0.67 N/A N/A$224.14M N/A N/A
2/21/13 Q412 -$0.43-$0.27 -$0.16$130.96M$129.7M = Details
2/16/12 Q411 -$0.23-$0.11 -$0.12$107.9M$115.3M = Details
10/24/13 Q313 -$0.38-$0.30 -$0.08$136.9M$140M = Details
4/26/12 Q112 -$0.21-$0.14 -$0.07$116.6M$119.24M = Details
8/1/12 Q212 -$0.27-$0.21 -$0.06$124M$121.54M = Details
4/25/13 Q113 -$0.31-$0.29 -$0.02N/A$131.44M = Details
8/3/15 Q215 -$0.51-$0.53 +$0.02$250M$218.16M Details